Portage Biotech Inc.

The momentum for this stock is not very good. Portage Biotech Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Portage Biotech Inc..

News

Portage Biotech reports Q2 EPS ($1.58) vs. ($6.69) last year

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2024 and Business Update

Globe Newswire Exploration and evaluation of strategic alternatives continueWESTPORT, Conn., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. ( Portage or the Company ) (NASDAQ: PRTG), a clinical-stage...\n more…

PRTG Stock Earnings: Portage Biotech Reported Results for Q4 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nPortage Biotech just reported results for the fourth quarter of 2024.\nThe post PRTG Stock Earnings: Portage Biotech Reported Results for...\n more…

Portage Biotech reports 2024 EPS ($3.89) vs. ($6.49) last year

Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business Update

Globe Newswire Exploration and evaluation of strategic alternatives continuePausing patient enrollment in the ADPORT-601 clinical trial (adenosine 2A and 2B inhibitors)Discontinuing the iNKT clinical trial for...\n more…